Differentiation of hemolytically active fluid-phase and cell-bound human C1q by an ant venom-derived polysaccharide.
D000818:Animals; D000862:Ant Venoms / Q000494:pharmacology*; D000906:Antibodies; D001180:Arthropod Venoms / Q000494:pharmacology*; D003167:Complement Activation; D003172:Complement C1; D003174:Complement C1 Inactivator Proteins; D003175:Complement C2; D003181:Complement C4; D004912:Erythrocytes / Q000276:immunology; D006168:Guinea Pigs; D006461:Hemolysis; D006801:Humans; D007111:Immunity, Cellular; D011134:Polysaccharides / Q000494:pharmacology*; D014316:Tritium
D000862:Ant Venoms; D000906:Antibodies; D001180:Arthropod Venoms; D003172:Complement C1; D003174:Complement C1 Inactivator Proteins; D003175:Complement C2; D003181:Complement C4; D011134:Polysaccharides; D014316:Tritium